Stories

Topic's Include: COVID-19 media only news briefing: managing influenza during a pandemic, Mayo Clinic Q and A: COVID-19 vaccine boosters and third doses, and COVID Queries: Delta breakthrough infections.

Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.

As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.

This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.

Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.

A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that provide inventive and essential solutions to broaden testing capabilities.

This weeks research roundup features Consensus-Based Recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A delphi consensus statement.

Topic's Include: 3 things you can do to stop the spread of COVID-19 regardless of whether you’re vaccinated, and monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19.

As a technical publications specialist, Pat Staley ensures that health care providers and laboratorians have the clear, concise, accurate information about Mayo Clinic Laboratories’ tests that they need to guide patient care.

This weeks research roundup features Diagnosis and classification of ileal pouch disorders: consensus guidelines from the international Ileal pouch consortium.

Topic's Include: FDA gives full approval to Pfizer COVID-19 vaccine, responding to increased demand for COVID-19 testing, vaccines and implementing visitor restrictions, and Mayo Clinic to offer COVID-19 vaccination walk-in clinics in Rochester through Sept. 17.

This week's research roundup features Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with Ibrutinib.